These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21053332)

  • 1. Telomere length of patients with major depression is shortened but independent from therapy and severity of the disease.
    Hartmann N; Boehner M; Groenen F; Kalb R
    Depress Anxiety; 2010 Dec; 27(12):1111-6. PubMed ID: 21053332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder.
    Huuhka K; Kampman O; Anttila S; Huuhka M; Rontu R; Mattila KM; Hurme M; Lehtimäki T; Leinonen E
    Neurosci Lett; 2008 May; 437(1):25-8. PubMed ID: 18434012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT
    J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxic effects of depression on brain function: impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients.
    Gorwood P; Corruble E; Falissard B; Goodwin GM
    Am J Psychiatry; 2008 Jun; 165(6):731-9. PubMed ID: 18381906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Easing the burden of treatment-resistant depression.
    J Clin Psychiatry; 2009 Feb; 70(2):273-80. PubMed ID: 19265643
    [No Abstract]   [Full Text] [Related]  

  • 6. A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder.
    Bauer M; El-Khalili N; Datto C; Szamosi J; Eriksson H
    J Affect Disord; 2010 Dec; 127(1-3):19-30. PubMed ID: 20884063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Major depressive disorder in suicide attempts among over 60 years old patients].
    Dabi E; Matusevich D; Finkelsztein C
    Vertex; 2003; 14(52):124-7. PubMed ID: 12883593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving depression outcome: new concepts, strategies and technologies.
    Alpert JE
    J Psychopharmacol; 2006 May; 20(3 Suppl):3-4. PubMed ID: 16644765
    [No Abstract]   [Full Text] [Related]  

  • 9. [Telomeres in the brain cortex of depressive patients].
    Teyssier JR; Ragot S; Donzel A; Chauvet-Gelinier JC
    Encephale; 2010 Dec; 36(6):491-4. PubMed ID: 21130233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression.
    Patankar TF; Baldwin R; Mitra D; Jeffries S; Sutcliffe C; Burns A; Jackson A
    J Affect Disord; 2007 Jan; 97(1-3):265-70. PubMed ID: 16919335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major depression: the importance of clinical characteristics and treatment response to prognosis.
    Katon W; Unützer J; Russo J
    Depress Anxiety; 2010; 27(1):19-26. PubMed ID: 19798766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.
    Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
    J Affect Disord; 2011 Jan; 128(1-2):56-63. PubMed ID: 20643483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions.
    Correll GE; Futter GE
    Pain Med; 2006; 7(1):92-5. PubMed ID: 16533209
    [No Abstract]   [Full Text] [Related]  

  • 14. Single nucleotide polymorphism in the drug transporter gene ABCB1 in treatment-resistant depression: clinical practice.
    Rosenhagen MC; Uhr M
    J Clin Psychopharmacol; 2010 Apr; 30(2):209-11. PubMed ID: 20520302
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible predictors of response to clonazepam augmentation therapy in patients with protracted depression.
    Morishita S; Arita S
    Hum Psychopharmacol; 2007 Jan; 22(1):27-31. PubMed ID: 17191267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Depressive onset episode of bipolar disorder: clinical and prognostic considerations].
    Besnier N; Fakra E; Kaladjian A; Adida M; Maurel M; Azorin JM
    Encephale; 2010 Jan; 36 Suppl 1():S18-22. PubMed ID: 20141803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying "paradigm failures" contributing to treatment-resistant depression.
    Parker GB; Malhi GS; Crawford JG; Thase ME
    J Affect Disord; 2005 Aug; 87(2-3):185-91. PubMed ID: 15979725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personality disorders improve in patients treated for major depression.
    Mulder RT; Joyce PR; Frampton CM
    Acta Psychiatr Scand; 2010 Sep; 122(3):219-25. PubMed ID: 19895619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results.
    Maina G; Rosso G; Bogetto F
    J Affect Disord; 2009 Apr; 114(1-3):200-7. PubMed ID: 18728001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.